Literature DB >> 28961017

Barriers to Medications for Addiction Treatment: How Stigma Kills.

Sarah E Wakeman1,2,3, Josiah D Rich3,4.   

Abstract

Mesh：

Year:  2017        PMID： 28961017     DOI： 10.1080/10826084.2017.1363238

Source DB:  PubMed          Journal:  Subst Use Misuse        ISSN： 1082-6084            Impact factor:   2.164


× No keyword cloud information.
  37 in total

1.  Medication for opioid use disorder treatment and specialty outpatient substance use treatment outcomes: Differences in retention and completion among opioid-related discharges in 2016.

Authors:  Melanie S Askari; Silvia S Martins; Pia M Mauro
Journal:  J Subst Abuse Treat       Date:  2020-05-11

2.  Attitudes toward opioid use disorder medications: Results from a U.S. national study of individuals who resolved a substance use problem.

Authors:  Brandon G Bergman; Robert D Ashford; John F Kelly
Journal:  Exp Clin Psychopharmacol       Date:  2019-09-26       Impact factor: 3.157

3.  The Washington State Hub and Spoke Model to increase access to medication treatment for opioid use disorders.

Authors:  Sharon Reif; Mary F Brolin; Maureen T Stewart; Thomas J Fuchs; Elizabeth Speaker; Shayna B Mazel
Journal:  J Subst Abuse Treat       Date:  2019-07-19

4.  Stigma and substance use disorders: A clinical, research, and advocacy agenda.

Authors:  Valerie A Earnshaw
Journal:  Am Psychol       Date:  2020-12

5.  Life after opioid-involved overdose: survivor narratives and their implications for ER/ED interventions.

Authors:  Luther Elliott; Alex S Bennett; Brett Wolfson-Stofko
Journal:  Addiction       Date:  2019-04-11       Impact factor: 6.526

6.  Differences in Availability and Use of Medications for Opioid Use Disorder in Residential Treatment Settings in the United States.

Authors:  Andrew S Huhn; J Gregory Hobelmann; Justin C Strickland; George A Oyler; Cecilia L Bergeria; Annie Umbricht; Kelly E Dunn
Journal:  JAMA Netw Open       Date:  2020-02-05

7.  Letting the sun shine on patient voices: Perspectives about medications for opioid use disorder in Florida.

Authors:  Amanda Sharp; Melissa Carlson; Veronica Howell; Kathleen Moore; Zev Schuman-Olivier
Journal:  J Subst Abuse Treat       Date:  2020-12-11

8.  Supporting individuals using medications for opioid use disorder in recovery residences: challenges and opportunities for addressing the opioid epidemic.

Authors:  Jennifer Miles; Jason Howell; Dave Sheridan; George Braucht; Amy Mericle
Journal:  Am J Drug Alcohol Abuse       Date:  2020-02-24       Impact factor: 3.829

9.  On my own terms: Motivations for self-treating opioid-use disorder with non-prescribed buprenorphine.

Authors:  Sydney M Silverstein; Raminta Daniulaityte; Shannon C Miller; Silvia S Martins; Robert G Carlson
Journal:  Drug Alcohol Depend       Date:  2020-03-16       Impact factor: 4.492

10.  Differential adoption of opioid agonist treatments in detoxification and outpatient settings.

Authors:  Kelly E Dunn; Andrew S Huhn; Eric C Strain
Journal:  J Subst Abuse Treat       Date:  2019-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.